Key Clinical Points Immune Thrombocytopenia Immune thrombocytopenia (ITP) is diagnosed
in patients with a platelet count below 100,000 per cubic millimeter in whom other causes …

… with thrombocytopenia 1 . Secondary ITP is defined as any form of immune thrombocytopenia
other than primary; these might include thrombocytopenia secondary to systemic lupus …

… ) or secondary to a growing list of associated conditions (secondary ITP), and must be
differentiated from other causes of thrombocytopenia. This review focuses on primary ITP in adults. …

… also exacerbates thrombocytopenia, due to an immune response against … ITP. In this
review, the major mechanisms leading to thrombocytopenia, the role of the different immune …

Immune thrombocytopenia (ITP) is an autoimmune disease defined by low platelet counts
which presents with an increased bleeding risk. Several genetic risk factors (eg, …

… eventually aid in management of patients with ITP. The IWG defined the abbreviation in
common use (ITP) to be Immune Thrombocytopenia (neither Idiopathic nor Purpura) because the …

… (immune) thrombocytopenic purpura (ITP) is a common autoimmune disorder resulting in
isolated thrombocytopenia. … of ITP remains unknown, complex dysregulation of the immune …

… immune thrombocytopenia (ITP). To this day, however, it is unclear whether the immune
abnormalities associated with ITP … Like the majority of all autoimmune diseases, ITP is an organ-…

… Primary immune thrombocytopenia (ITP) is an acquired immune disorder characterized
by an isolated thrombocytopenia (peripheral blood platelet count <100 × 10 9 /L) [1] due to …

… changes in the management of ITP. Current treatment approaches for ITP are more rational
and … Whilst corticosteroids are the mainstay of initial ITP treatment their use should be limited. …